Stem cell-based therapies for atherosclerosis: Perspectives and ongoing controversies

Stem Cells and Development

Volumn 23, Issue 15, 2014, Pages 1731-1740

  Zhang, Na ^a   Xie, Xiaojie ^a   Chen, Huiqiang ^a   Chen, Han ^a   Yu, Hong ^a   Wang, Jian An ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT STEM CELL; ATHEROSCLEROSIS; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; LIPID METABOLISM; MESENCHYMAL STEM CELL; METABOLIC REGULATION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE PROGENITOR CELL; STEM CELL; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; ANIMAL; CYTOLOGY; DISEASE MODEL; METABOLISM;

ANIMALS; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84904705779     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0078     Document Type: Review

References (109)

1. Go AS, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ES Ford, CS Fox, et al.;(2014). on behalf of the American Heart Association Statistics and S Stroke Statistics. Heart disease and stroke statistics-2014 update: A report from the American Heart Association. Circulation 129:e28-e292.
2. Libby P, PM Ridker and A Maseri. (2002). Inflammation and atherosclerosis. Circulation 105:1135-1143.
3. Glass CK and JL Witztum. (2001). Atherosclerosis the road ahead. Cell 104:503-516.
4. Ross R. (1999). Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126.
5. Libby P, PM Ridker and GK Hansson. (2011). Progress and challenges in translating the biology of atherosclerosis. Nature 473:317-325.
6. Gimbrone MA, Jr., JN Topper, T Nagel, KR Anderson and G Garcia-Cardena. (2000). Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 902:230-239; discussion 239-240.
7. Cai H and DG Harrison. (2000). Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res 87:840-844.
8. Ludmer PL, AP Selwyn, TL Shook, RR Wayne, GH Mudge, RW Alexander and P Ganz. (1986). Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315:1046-1051.
9. Davignon J and P Ganz. (2004). Role of endothelial dysfunction in atherosclerosis. Circulation 109:III27-III32.
10. Ross R, J Glomset and L Harker. (1977). Response to injury and atherogenesis. Am J Pathol 86:675-684.
11. Vogel RA, MC Corretti and J Gellman. (1998). Cholesterol, cholesterol lowering, and endothelial function. Prog Cardiovasc Dis 41:117-136.
12. Asahara T, T Murohara, A Sullivan, M Silver, R van der Zee, T Li, B Witzenbichler, G Schatteman and JM Isner. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967.
13. Asahara T, H Masuda, T Takahashi, C Kalka, C Pastore, M Silver, M Kearne, M Magner and JM Isner. (1999). Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228.
14. Foteinos G, Y Hu, Q Xiao, B Metzler and Q Xu. (2008). Rapid endothelial turnover in atherosclerosis-prone areas coincides with stem cell repair in apolipoprotein E-deficient mice. Circulation 117:1856-1863.
15. Majesky MW, XR Dong, JN Regan and VJ Hoglund. (2011). Vascular smooth muscle progenitor cells: Building and repairing blood vessels. Circ Res 108:365-377.
16. Caplice NM, TJ Bunch, PG Stalboerger, S Wang, D Simper, DV Miller, SJ Russell, MR Litzow and WD Edwards. (2003). Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci USA 100: 4754-4759.
17. Metharom P, AH Kumar, S Weiss and NM Caplice. (2010). A specific subset of mouse bone marrow cells has smooth muscle cell differentiation capacity-brief report. Arterioscler Thromb Vasc Biol 30:533-535.
18. Kumar AH, P Metharom, J Schmeckpeper, S Weiss, K Martin and NM Caplice. (2010). Bone marrow-derived CX3CR1 progenitors contribute to neointimal smooth muscle cells via fractalkine CX3CR1 interaction. FASEB J 24:81-92.
19. Lusis AJ. (2000). Atherosclerosis. Nature 407:233-241.
20. Falk E. (2006). Pathogenesis of atherosclerosis. J Am Coll Cardiol 47:C7-C12.
21. Doran AC, N Meller and CA McNamara. (2008). Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28:812-819.
22. Raines EW and R Ross. (1993). Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J 69:S30-S37.
23. Xu Q. (2008). Stem cells and transplant arteriosclerosis. Circ Res 102:1011-1024.
24. Ross R and L Harker. (1976). Hyperlipidemia and atherosclerosis. Science 193:1094-1100.
25. Heiss C, S Keymel, U Niesler, J Ziemann, M Kelm and C Kalka. (2005). Impaired progenitor cell activity in agerelated endothelial dysfunction. J Am Coll Cardiol 45: 1441-1448.
26. Loomans CJ, EJ de Koning, FJ Staal, MB Rookmaaker, C Verseyden, HC de Boer, MC Verhaar, B Braam, TJ Rabelink and AJ van Zonneveld. (2004). Endothelial progenitor cell dysfunction: A novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53:195-199.
27. Fadini GP, M Albiero, S Vigili de Kreutzenberg, E Boscaro, R Cappellari, M Marescotti, N Poncina, C Agostini and A Avogaro. (2013). Diabetes impairs stem cell and proangiogenic cell mobilization in humans. Diabetes Care 36:943-949.
28. Dimmeler S and A Leri. (2008). Aging and disease as modifiers of efficacy of cell therapy. Circ Res 102:1319-1330.
29. Assmus B, V Schachinger, C Teupe, M Britten, R Lehmann, N Dobert, F Grunwald, A Aicher, C Urbich, et al. (2002). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106:3009-3017.
30. Stamm C, B Westphal, HD Kleine, M Petzsch, C Kittner, H Klinge, C Schumichen, CA Nienaber, M Freund and G Steinhoff. (2003). Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361: 45-46.
31. Chen S, Z Liu, N Tian, J Zhang, F Yei, B Duan, Z Zhu, S Lin and TW Kwan. (2006). Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. J Invasive Cardiol 18:552-556.
32. Rauscher FM, PJ Goldschmidt-Clermont, BH Davis, T Wang, D Gregg, P Ramaswami, AM Pippen, BH Annex, C Dong and DA Taylor. (2003). Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108:457-463.
33. Silvestre JS, A Gojova, V Brun, S Potteaux, B Esposito, M Duriez, M Clergue, S Le Ricousse-Roussanne, V Barateau, et al. (2003). Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition. Circulation 108:2839-2842.
34. George J, A Afek, A Abashidze, H Shmilovich, V Deutsch, J Kopolovich, H Miller and G Keren. (2005). Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 25:2636-2641.
35. Hagensen MK, J Shim, T Thim, E Falk and JF Bentzon. (2010). Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis. Circulation 121:898-905.
36. Plump AS, JD Smith, T Hayek, K Aalto-Setala, A Walsh, JG Verstuyft, EM Rubin and JL Breslow. (1992). Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71:343-353.
37. Zhang SH, RL Reddick, JA Piedrahita and N Maeda. (1992). Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471.
38. Nakashima Y, AS Plump, EW Raines, JL Breslow and R Ross. (1994). ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14:133-140.
39. Basu SK, MS Brown, YK Ho, RJ Havel and JL Goldstein. (1981). Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E. Proc Natl Acad Sci USA 78:7545-7549.
40. Linton MF, JB Atkinson and S Fazio. (1995). Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science 267:1034-1037.
41. Fazio S, VR Babaev, AB Murray, AH Hasty, KJ Carter, LA Gleaves, JB Atkinson and MF Linton. (1997). Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci USA 94:4647-4652.
42. Van Eck M, N Herijgers, M Vidgeon-Hart, NJ Pearce, PM Hoogerbrugge, PH Groot and TJ Van Berkel. (2000). Accelerated atherosclerosis in C57Bl/6 mice transplanted with ApoE-deficient bone marrow. Atherosclerosis 150:71-80.
43. Brown MS and JL Goldstein. (1986). A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47.
44. Roselaar SE, PX Kakkanathu and A Daugherty. (1996). Lymphocyte populations in atherosclerotic lesions of apoE-/-and LDL receptor-/-mice. Decreasing density with disease progression. Arterioscler Thromb Vasc Biol 16:1013-1018.
45. Herijgers N, M Van Eck, PH Groot, PM Hoogerbrugge and TJ Van Berkel. (1997). Effect of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor-knockout mice. Arterioscler Thromb Vasc Biol 17:1995-2003.
46. Getz GS and CA Reardon. (2006). Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol 26:242-249.
47. Lieu HD, SK Withycombe, Q Walker, JX Rong, RL Walzem, JS Wong, RL Hamilton, EA Fisher and SG Young. (2003). Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion. Circulation 107:1315-1321.
48. Feig JE, S Parathath, JX Rong, SL Mick, Y Vengrenyuk, L Grauer, SG Young and EA Fisher. (2011). Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques. Circulation 123:989-998.
49. Yao L, J Heuser-Baker, O Herlea-Pana, R Iida, Q Wang, MH Zou and J Barlic-Dicen. (2012). Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering. Stem Cells 30:2720-2731.
50. Werner N, J Priller, U Laufs, M Endres, M Bohm, U Dirnagl and G Nickenig. (2002). Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: Effect of 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 22:1567-1572.
51. Walter DH, K Rittig, FH Bahlmann, R Kirchmair, M Silver, T Murayama, H Nishimura, DW Losordo, T Asahara and JM Isner. (2002). Statin therapy accelerates reendothelialization: A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105:3017-3024.
52. Werner N, S Junk, U Laufs, A Link, K Walenta, M Bohm and G Nickenig. (2003). Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93:e17-e24.
53. Laufs U, N Werner, A Link, M Endres, S Wassmann, K Jurgens, E Miche, M Bohm and G Nickenig. (2004). Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109:220-226.
54. Strehlow K, N Werner, J Berweiler, A Link, U Dirnagl, J Priller, K Laufs, L Ghaeni, M Milosevic, M Bohm and G Nickenig. (2003). Estrogen increases bone marrowderived endothelial progenitor cell production and diminishes neointima formation. Circulation 107:3059-3065.
55. Kong D, LG Melo, M Gnecchi, L Zhang, G Mostoslavsky, CC Liew, RE Pratt and VJ Dzau. (2004). Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 110:2039-2046.
56. Urao N, M Okigaki, H Yamada, Y Aadachi, K Matsuno, A Matsui, S Matsunaga, K Tateishi, T Nomura, et al. (2006). Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 98:1405-1413.
57. Takahashi T, C Kalka, H Masuda, D Chen, M Silver, M Kearney, M Magner, JM Isner and T Asahara. (1999). Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5:434-438.
58. Dimmeler S, A Aicher, M Vasa, C Mildner-Rihm, K Adler, M Tiemann, H Rutten, S Fichtlscherer, H Martin and AM Zeiher. (2001). HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108:391-397.
59. Akhtar S, F Gremse, F Kiessling, C Weber and A Schober. (2013). CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice. Arterioscler Thromb Vasc Biol 33:679-686.
60. Yamamoto T, R Shibata, M Ishii, N Kanemura, T Kito, H Suzuki, H Miyake, K Maeda, T Tanigawa, N Ouchi and T Murohara. (2013). Therapeutic reendothelialization by induced pluripotent stem cells after vascular injury-brief report. Arterioscler Thromb Vasc Biol 33:2218-2221.
61. Potteaux S, EL Gautier, SB Hutchison, N van Rooijen, DJ Rader, MJ Thomas, MG Sorci-Thomas and GJ Randolph. (2011). Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/-mice during disease regression. J Clin Invest 121:2025-2036.
62. Bairey Merz CN, LJ Shaw, SE Reis, V Bittner, SF Kelsey, M Olson, BD Johnson, CJ Pepine, S Mankad, et al.; WISE Investigators. (2006). Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: Gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 47:S21-S29.
63. Nelson WD, AG Zenovich, HC Ott, C Stolen, GJ Caron, A Panoskaltsis-Mortari, SA Barnes, 3rd, X Xin and DA Taylor. (2007). Sex-dependent attenuation of plaque growth after treatment with bone marrow mononuclear cells. Circ Res 101:1319-1327.
64. Diehm C, JR Allenberg, D Pittrow, M Mahn, G Tepohl, RL Haberl, H Darius, I Burghaus, HJ Trampisch and G German Epidemiological Trial on Ankle Brachial Index Study. (2009). Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 120:2053-2061.
65. Tousoulis D, A Briasoulis, G Vogiatzi, A Valatsou, P Kourkouti, A Pantopoulou, N Papageorgiou, D Perrea and C Stefanadis. (2013). Infusion of lin-/sca-1 + and endothelial progenitor cells improves proinflammatory and oxidative stress markers in atherosclerotic mice. Int J Cardiol 167:1900-1905.
66. Song X, Q Ma, X Liu, P Seo, E Herderick, K Webster, PJ Goldschmidt-Clermont and D Seo. (2012). Will periodic intravenous injections of conditioned bone marrow cells effectively reduce atherosclerosis? Antioxid Redox Signal 16:85-91.
67. Wassmann S, N Werner, T Czech and G Nickenig. (2006). Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res 99:e74-e83.
68. Sata M, A Saiura, A Kunisato, A Tojo, S Okada, T Tokuhisa, H Hirai, M Makuuchi, Y Hirata and R Nagai. (2002). Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8:403-409.
69. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
70. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, XR Ortiz-Gonzalez, M Reyes, T Lenvik, T Lund, et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
71. Sato K, K Ozaki, I Oh, A Meguro, K Hatanaka, T Nagai, K Muroi and K Ozawa. (2007). Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109:228-234.
72. Yue WM, W Liu, YW Bi, XP He, WY Sun, XY Pang, XH Gu and XP Wang. (2008). Mesenchymal stem cells differentiate into an endothelial phenotype, reduce neointimal formation, and enhance endothelial function in a rat vein grafting model. Stem Cells Dev 17:785-793.
73. Oswald J, S Boxberger, B Jorgensen, S Feldmann, G Ehninger, M Bornhauser and C Werner. (2004). Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22:377-384.
74. Eirin A, XY Zhu, JD Krier, H Tang, KL Jordan, JP Grande, A Lerman, SC Textor and LO Lerman. (2012). Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells 30:1030-1041.
75. Wang CH, WJ Cherng, NI Yang, LT Kuo, CM Hsu, HI Yeh, YJ Lan, CH Yeh and WL Stanford. (2008). Lateoutgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscler Thromb Vasc Biol 28:54-60.
76. Asahara T, T Takahashi, H Masuda, C Kalka, D Chen, H Iwaguro, Y Inai, M Silver and JM Isner. (1999). VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18:3964-3972.
77. Aicher A and C Heeschen. (2007). Nonbone marrowderived endothelial progenitor cells: What is their exact location? Circ Res 101:e102.
78. Isner JM and T Asahara. (1999). Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 103:1231-1236.
79. Rehman J, J Li, CM Orschell and KL March. (2003). Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107:1164-1169.
80. Folkman J and Y Shing. (1992). Angiogenesis. J Biol Chem 267:10931-10934.
81. Ingram DA, NM Caplice and MC Yoder. (2005). Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 106:1525-1531.
82. Fadini GP, D Losordo and S Dimmeler. (2012). Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 110:624-637.
83. Hur J, CH Yoon, HS Kim, JH Choi, HJ Kang, KK Hwang, BH Oh, MM Lee and YB Park. (2004). Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24:288-293.
84. Sieveking DP, A Buckle, DS Celermajer and MK Ng. (2008). Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: Insights from a novel human angiogenesis assay. J Am Coll Cardiol 51: 660-668.
85. Lin Y, DJ Weisdorf, A Solovey and RP Hebbel. (2000). Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105:71-77.
86. Kalka C, H Masuda, T Takahashi, WM Kalka-Moll, M Silver, M Kearney, T Li, JM Isner and T Asahara. (2000). Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97:3422-3427.
87. Vasa M, S Fichtlscherer, A Aicher, K Adler, C Urbich, H Martin, AM Zeiher and S Dimmeler. (2001). Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:E1-E7.
88. Hill JM, G Zalos, JP Halcox, WH Schenke, MA Waclawiw, AA Quyyumi and T Finkel. (2003). Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593-600.
89. Sethi R and CH Lee. (2012). Endothelial progenitor cell capture stent: Safety and effectiveness. J Interv Cardiol 25:493-500.
90. Zoll J, V Fontaine, P Gourdy, V Barateau, J Vilar, A Leroyer, I Lopes-Kam, Z Mallat, JF Arnal, et al. (2008). Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition. Cardiovasc Res 77:471-480.
91. Ross R. (1993). The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801-809.
92. Schwartz SM, R Virmani and ME Rosenfeld. (2000). The good smooth muscle cells in atherosclerosis. Curr Atheroscler Rep 2:422-429.
93. Virmani R, AP Burke, A Farb and FD Kolodgie. (2006). Pathology of the vulnerable plaque. J Am Coll Cardiol 47:C13-C18.
94. Clarke MC, N Figg, JJ Maguire, AP Davenport, M Goddard, TD Littlewood and MR Bennett. (2006). Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 12:1075-1080.
95. Bentzon JF, C Weile, CS Sondergaard, J Hindkjaer, M Kassem and E Falk. (2006). Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol 26:2696-2702.
96. Hoofnagle MH, JA Thomas, BR Wamhoff and GK Owens. (2006). Origin of neointimal smooth muscle: We've come full circle. Arterioscler Thromb Vasc Biol 26:2579-2581.
97. Han CI, GR Campbell and JH Campbell. (2001). Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res 38:113-119.
98. Hillebrands JL, FA Klatter, BM van den Hurk, ER Popa, P Nieuwenhuis and J Rozing. (2001). Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 107:1411-1422.
99. Shimizu K, S Sugiyama, M Aikawa, Y Fukumoto, E Rabkin, P Libby and RN Mitchell. (2001). Host bonemarrow cells are a source of donor intimal smoothmuscle-like cells in murine aortic transplant arteriopathy. Nat Med 7:738-741.
100. Simper D, PG Stalboerger, CJ Panetta, S Wang and NM Caplice. (2002). Smooth muscle progenitor cells in human blood. Circulation 106:1199-1204.
101. Iwata H, I Manabe, K Fujiu, T Yamamoto, N Takeda, K Eguchi, A Furuya, M Kuro-o, M Sata and R Nagai. (2010). Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth muscle cell lineages. Circulation 122:2048-2057.
102. Yu H, V Stoneman, M Clarke, N Figg, HB Xin, M Kotlikoff, T Littlewood and M Bennett. (2011). Bone marrow-derived smooth muscle-like cells are infrequent in advanced primary atherosclerotic plaques but promote atherosclerosis. Arterioscler Thromb Vasc Biol 31:1291-1299.
103. Baraniak PR and TC McDevitt. (2010). Stem cell paracrine actions and tissue regeneration. Regen Med 5:121-143.
104. Gnecchi M, Z Zhang, A Ni and VJ Dzau. (2008). Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103:1204-1219.
105. Segers VF and RT Lee. (2008). Stem-cell therapy for cardiac disease. Nature 451:937-942.
106. Zernecke A, K Bidzhekov, H Noels, E Shagdarsuren, L Gan, B Denecke, M Hristov, T Koppel, MN Jahantigh, et al. (2009). Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2: 81.
107. Kong D, LG Melo, AA Mangi, L Zhang, M Lopez-Ilasaca, MA Perrella, CC Liew, RE Pratt and VJ Dzau. (2004). Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 109:1769-1775.
108. Zhang QJ, Z Wang, HZ Chen, S Zhou, W Zheng, G Liu, YS Wei, H Cai, DP Liu and CC Liang. (2008). Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res 80:191-199.
109. Nissen SE, SJ Nicholls, I Sipahi, P Libby, JS Raichlen, CM Ballantyne, J Davignon, R Erbel, JC Fruchart, et al. (2006). Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 295:1556-1565.